Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.

Goater J, Müller R, Kollias G, Firestein GS, Sanz I, O'Keefe RJ, Schwarz EM.

J Rheumatol. 2000 Apr;27(4):983-9.

PMID:
10782827
2.

Gene therapy and transplantation in the retinofugal pathway.

Harvey AR, Hellström M, Rodger J.

Prog Brain Res. 2009;175:151-61. doi: 10.1016/S0079-6123(09)17510-6. Review.

PMID:
19660654
4.

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease.

Bankiewicz KS, Leff SE, Nagy D, Jungles S, Rokovich J, Spratt K, Cohen L, Libonati M, Snyder RO, Mandel RJ.

Exp Neurol. 1997 Mar;144(1):147-56. Review.

PMID:
9126164
5.

Biologic aspects of expression of stably integrated transgenes in cells of the skin in vitro and in vivo.

Krueger GG, Morgan JR, Petersen MJ.

Proc Assoc Am Physicians. 1999 May-Jun;111(3):198-205. Review.

PMID:
10354359
6.

Novel therapeutic strategies involving animals, arthritis, and apoptosis.

Firestein GS.

Curr Opin Rheumatol. 1998 May;10(3):236-41. Review.

PMID:
9608326
7.

Gene transfer to synoviocytes: prospects for gene treatment of arthritis.

Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH.

DNA Cell Biol. 1992 Apr;11(3):227-31. Review.

PMID:
1567555
8.

Cellular transduction mechanisms of adeno-associated viral vectors.

Berry GE, Asokan A.

Curr Opin Virol. 2016 Dec;21:54-60. doi: 10.1016/j.coviro.2016.08.001. Epub 2016 Aug 18. Review.

PMID:
27544821
9.

Arthritis gene therapy and its tortuous path into the clinic.

Evans CH, Ghivizzani SC, Robbins PD.

Transl Res. 2013 Apr;161(4):205-16. doi: 10.1016/j.trsl.2013.01.002. Epub 2013 Jan 29. Review.

10.

Arthritis.

Evans CH, Robbins PD.

Mol Cell Biol Hum Dis Ser. 1995;5:252-60. Review. No abstract available.

PMID:
9532570

Supplemental Content

Support Center